Editor's Note Effective July 1, telehealth providers can apply for a new Joint Commission accreditation designed to ensure safe, high-quality care. Announced April 23 by The Joint Commission, the new Telehealth Accreditation Program is designed for organizations that exclusively provide care, treatment and services via telehealth. Hospitals and other healthcare…
Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…
Editor's Note Reports of spontaneous backup battery failure in Dreager Inc.’s Perseus A500 anesthesia workstation and multiple failures in InfuTronix, LLC’s Nimbus infusion pump systems prompted the FDA to classify manufacturer recalls as class 1, the most serious categorization indicating risk of serious harm or death. According to an April…
Editor's Note A study published March 30 in Nurse Education in Practice found that the majority of nurses with less than 2 years of work experience are uncomfortable performing more complex procedures independently. Conducted by Singapore General Hospital, Sengkang General Hospital, and Singapore Institute of Technology, the study aimed to…
Editor's Note The second-ever living recipient of a gene-edited pig kidney was the first to have the new organ paired with a mechanical heart pump, according to an April 24 CNN report. The subject, 54-year-old Lisa Pisano, underwent the milestone surgery at NYU Langone Health. She had heart failure and…
Editor's Note The US Food and Drug Administration has designated DeRoyal Industries’ recall of GeoMed custom tracecarts a class 1, the most serious type of recall indicating a risk of serious injury or death. According to the April 24 FDA notice, the recall is due to sterility concerns with the…
Editor's Note Personal information about a “substantial portion of people in America” could be at risk from the February 21 cyberattack on UnitedHealth’s Change Healthcare division, The Associated Press reported April 23. Although the company reports no signs of full medical histories or charts were released, notifying all who were…
Editor's Note How does your experience compare to that of your fellow perioperative leaders? The 2024 Salary/Career Survey is your chance to find out—and to contribute to the education of the broader community. We’ve published an article on a decade's worth of data from the annual survey in every issue…
Editor's Note Released April 9 by the Association for Supply Chain Management (ASCM) and KPMG LLP, the KPMG Supply Chain Stability Index reveals an overall improvement in supply chain stability throughout 2023. However, points of weakness persist. According to the index, factors preventing a complete return to pre-pandemic normalcy include the…
Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…